Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Naval Daver

Leukemia · MD Anderson Cancer Center

View

Dr. Daniel Pollyea

Leukemia · CU Anschutz Medical Campus

View

Dr. Jessica Altman

Leukemia · Northwestern Medicine

View

Dr. Shella Saint Fleur-Lominy

Leukemia · UMSOM

View

Dr. Azra Raza

Leukemia · CUIMC

View

Dr. Molly Imgruet

Leukemia · Stanford

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    RDDr. Ritika Dutta

    Dr. Ritika Dutta

    Hematology & Oncology · Leukemia
    Stanford Medicine
    ritika

    Research

    ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disorders.

    2025

    Via The Journal of Clinical Investigation

    Research

    Understanding inequities in precision oncology diagnostics.

    2023

    Via Nature Cancer

    Research

    The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia.

    2022

    Via Blood Cancer Discovery

    Research

    Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report.

    2021

    Via Journal of Medical Case Reports

    Research

    Financial Toxicity of Cancer Care: An Analysis of Financial Burden in Three Distinct Health Care Systems.

    2021

    Via JCO Oncology Practice

    Research

    Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2.

    2020

    Via The Journal of Clinical Investigation

    Research

    IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia.

    2020

    Via Science Translational Medicine

    Research

    Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience.

    2020

    Via Leukemia & Lymphoma

    Research

    RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit.

    2020

    Via Oncotarget

    Research

    Improved outcomes of octogenarians and nonagenarians with acute myeloid leukemia in the era of novel therapies.

    2020

    Via American Journal of Hematology

    Research

    Small molecule screen for inhibitors of expression from canonical CREB response element-containing promoters.

    2016

    Via Oncotarget

    Research

    CBP/p300 acetyltransferase activity in hematologic malignancies.

    2016

    Via Molecular Genetics and Metabolism